Evaluation of M7824 a bifunctional fusion protein targeting TGF and PDL1 in patients with HPVassociated malignancies

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies

11:58 EDT 15 Apr 2019 | ecancermedicalscience

Dr James Gulley speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about a study looking at M7824 (a bifunctional fusion protein targeting TGF-β and PD-L1) in patients with HPV-associated malignancies. Dr Gulley...

More From BioPortfolio on "Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies"